Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-941-3 | CAS number: 86960-46-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: other: cytogenetic damage
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well performed GLP and OECD guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Korea Food & Drug Administration, Notification No. 1999-61, Standards for Toxicity Study of Drugs, etc., 1999.12.22.
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- DOBA
- IUPAC Name:
- DOBA
- Reference substance name:
- Benzoic acid, 4-[ (1-oxodecyl) oxy]-
- EC Number:
- 617-941-3
- Cas Number:
- 86960-46-5
- Molecular formula:
- C17H24O4;
- IUPAC Name:
- Benzoic acid, 4-[ (1-oxodecyl) oxy]-
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Strain: NMRI
Charles River Laboratories
Research Models and Services Germany GmbH
Sandhofer Weg 7, 97633 Sulzfeld, Germany
Number of animals: 72 (36 males and 36 females)
Acclimation: minimum 5 days
Initial age at start
of experiment: 9 - 10 weeks
Initial Body Weight
at Start of Treatment: males: mean value 36.7 g (SD +/- 1.9 g)
females: mean value 30.2 g (SD +/- 1.8 g)
ENVIRONMENTAL CONDITIONS
Housing: single / group
Cage Type: Makrolon Type II/III, with wire mesh top
(EHRET GmbH, 79302 Emmendingen, Germany)
Bedding: granulated soft wood bedding
(Rettenmaier & Söhne GmbH + Co. KG,
73494 Rosenberg, Germany)
Feed: pelleted standard diet, ad libitum
(Harlan Laboratories B.V.
Postbus 6174, 5960 AD Horst, The Netherlands)
Water: tap water, ad libitum,
(Gemeindewerke, 64380 Rossdorf, Germany)
Environment: temperature 22 + 2 °C
relative humidity 45 - 65 %
artificial light 6.00 a.m. - 6.00 p.m.
IN-LIFE DATES: From: June 30, 2011 To: July 18, 2011
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Name: 30% DMSO / 70% PEG 400
Supplier: VWR
64295 Darmstadt, Germany
Catalogue no.: DMSO: 1.02931.1000 / PEG 400: 1.09726.0100
Batch: DMSO: K41607131109 / PEG 400: K34767126
Expiry Date: February 23, 2011
Route and Frequency
of Administration: orally, once
Volume administered: 10 mL/kg b.w. - Details on exposure:
- orally
- Frequency of treatment:
- once
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 1000, and 2000 mg/kg b.w.
Basis:
- No. of animals per sex per dose:
- 2 males, 2 females used in the pre-experiment
72 (36 males and 36 females) used in the main experiment - Control animals:
- yes
- Positive control(s):
- Name: CPA; Cyclophosphamide
Supplier: Fisher Scientific GmbH
61130 Nidderau, Germany
Catalogue no.: 203960010
Batch: A0277203
Expiry Date: December, 2011
Dissolved in: sterile water
Dosing: 40 mg/kg b.w.
Route and Frequency
of Administration: orally, once
Volume administered: 10 mL/kg b.w.
Solution prepared on day of administration.
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- The animals were sacrificed using CO2 followed by bleeding. The femora were removed, the epiphyses were cut off and the marrow was flushed out with foetal calf serum using a syringe. The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded. A small drop of the re-suspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald (Merck, 64293 Darmstadt, Germany)/Giemsa (Merck, 64293 Darmstadt, Germany). Cover slips were mounted with EUKITT (Kindler, 79110 Freiburg, Germany). At least one slide was made from each bone marrow sample.
- Evaluation criteria:
- Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives. Per animal 2000 polychromatic erythrocytes (PCE) were analysed for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and expressed in polychromatic erythrocytes per 2000 erythrocytes. The analysis was performed with coded slides.
All animals per test group were evaluated as described.
The study was considered valid as the following criteria are met:
- at least 5 animals per group can be evaluated.
- PCE to erythrocyte ratio should not be less than 20 % of the negative control.
- the positive control shows a statistically significant and biological relevant increase of micronucleated PCEs compared to the vehicle control. - Statistics:
- nonparametric Mann-Whitney test; p <0.05
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- ruffled fur
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Toxic Symptoms
RESULTS OF RANGE-FINDING STUDY
In a pre-experiment 4 animals (2 males, 2 females) received once orally a single dose of 2000 mg/kg b.w. DOBA formulated in 30% DMSO / 70% PEG 400. The volume administered was 10 mL/kg b.w..
The animals treated with 2000 mg/kg b.w. expressed toxic reactions as shown in the table:
toxic reactions observed: ruffled fur
hours post-treatment: 1 / 2-4 / 6 / 24 / 48
number of animals (male/female): 0/0 - 0/0 - 1/0 - 1/0 - 0/0
On the basis of these data 2000 mg/kg b.w. was chosen as highest treatment dose.
RESULTS OF DEFINITIVE STUDY
In the main experiment for the high dose groups 12 males and 12 females received orally a single dose of 2000 mg/kg b.w. DOBA formulated in 30% DMSO / 70% PEG 400. The volume administered was 10 mL/kg b.w..
The animals treated with 2000 mg/kg b.w. did not express any toxic reactions. The 6h observation interval was missed out.
For the mid dose group six males and six females received orally a single dose of 1000 mg/kg b.w. DOBA formulated in 30% DMSO / 70% PEG 400, respectively. The volume administered was 10 mL/kg b.w..
The animals treated with 1000 mg/kg b.w. expressed toxic reactions as shown in the table:
toxic reactions observed: ruffled fur
hours post-treatment: 1 / 2-4 / 24
number of animals (male/female): 0/0 - 3/5 - 0/0
For the low dose group six males and six females received orally a single dose of 500 mg/kg b.w. DOBA formulated in 30% DMSO / 70% PEG 400, respectively. The volume administered was 10 mL/kg b.w..
All treated animals for the low dose group (the 6h observation interval was missed out) as well as the animals treated with the vehicle control (30% DMSO / 70% PEG 400) did not express any toxic reactions.
Any other information on results incl. tables
Summary of Micronucleus Test Results
test group |
dose mg/kg b.w. |
sampling time (h) |
PCEs with micronuclei (%) |
range |
PCE per 2000erythocytes |
vehicle |
0 |
24 |
0.117 |
0 -5 |
1171 |
test item |
500 |
24 |
0.175 |
2 -10 |
1260 |
test item |
1000 |
24 |
0.133 |
0 -5 |
1252 |
test item |
2000 |
24 |
0.158 |
1 -6 |
1208 |
positive control |
40 |
24 |
2.354 |
30 - 78 |
1197 |
test item |
2000 |
48 |
0.108 |
1 -5 |
1317 |
Biometry
Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the non-parametric Mann-Whitney test.
Negative control versus test group |
Significance | p |
500 mg DOBA/kg b.w.; 24 h | - | 0.0959 |
1000 mg DOBA /kg b.w.; 24 h | - | 0.3420 |
2000 mg DOBA /kg b.w.; 24 h | - | 0.0957 |
40 mg CPA/kg b.w.; 24 h | + | <0.0001 |
2000 mg DOBA /kg b.w.; 48 h | n.t. | - |
- = not
significant
+ = significant
n.t. = not
tested, as the mean micronucleus frequency was not above the vehicle
control
value
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
In conclusion, it can be stated that during the study described and under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test in the bone marrow cells of the mouse. - Executive summary:
The test item DOBA was assessed in the micronucleus assay for its potential to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse.
The test item was formulated in 30% DMSO / 70% PEG 400, which was also used as vehicle control. The volume administered was 10 mL/kg b.w.once orally. 24 h and 48 h after a single administration of the test item the bone marrow cells were collected for micronuclei analysis.
Six males and six females per test group were evaluated for the occurrence of micronuclei. Per animal 2000 polychromatic erythrocytes (PCEs) were scored for micronuclei.
To describe a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and reported as the number of PCEs per 2000 erythrocytes.
The following dose levels of the test item were investigated:
24 h preparation interval: 500, 1000, and 2000 mg/kg b.w..
48 h preparation interval: 2000 mg/kg b.w..
As estimated by a pre-experiment 2000 mg DOBA per kg b.w. (the maximum guideline-recommended dose) was suitable.
The mean number of polychromatic erythrocytes was not decreased after treatment with the test item as compared to the mean value of PCEs of the vehicle control indicating that DOBA did not have any cytotoxic properties in the bone marrow.
In comparison to the corresponding vehicle controls there was no statistically significant or biologically relevant enhancement in the frequency of the detected micronuclei at any preparation interval and dose level after administration of the test item. The mean values of micronuclei observed after treatment with DOBA were below or near to the value of the vehicle control group and all within the historical vehicle control data range.
40 mg/kg b.w. cyclophosphamide administered orally was used as positive control which showed a statistically significant increase of induced micronucleus frequency.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.